Bank Julius Baer & Co’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-622
Closed -$70K 578
2023
Q3
$70K Sell
622
-2,761
-82% -$351K ﹤0.01% 448
2023
Q2
$493K Buy
3,383
+257
+8% +$34.9K ﹤0.01% 332
2023
Q1
$404K Buy
3,126
+616
+25% +$77.3K ﹤0.01% 366
2022
Q4
$320K Buy
+2,510
New +$291K ﹤0.01% 380
2022
Q2
Sell
-160
Closed -$20K 631
2022
Q1
$20K Buy
+160
New +$19.3K ﹤0.01% 558
2021
Q1
Sell
-368
Closed -$55K 912
2020
Q4
$55K Sell
368
-1,343
-78% -$190K ﹤0.01% 673
2020
Q3
$226K Sell
1,711
-319
-16% -$41.7K ﹤0.01% 487
2020
Q2
$235K Sell
2,030
-2,388
-54% -$275K ﹤0.01% 439
2020
Q1
$434K Buy
+4,418
New +$579K 0.01% 331

Other funds holding ZBH

Bank Julius Baer & Co's ZBH Position: Q4 2023 in Review

Bank Julius Baer & Co sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 622 shares — an estimated $70K sold.

Bank Julius Baer & Co first reported a position in ZBH in Q1 2020 and held it in 9 quarters. The position peaked at $493K in Q2 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • Bank Julius Baer & Co reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • Bank Julius Baer & Co sold 622 Zimmer Biomet shares in Q4 2023, an estimated $70K.
  • Bank Julius Baer & Co first reported a position in Zimmer Biomet in Q1 2020 and held it in 9 quarters.
  • Bank Julius Baer & Co's Zimmer Biomet position peaked at $493K in Q2 2023.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Bank Julius Baer & Co's 13F filing for Q4 2023, filed 2 Feb 2024.